Kazia Therapeutics Limited Asset Turnover Ratio (KZIA), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kazia Therapeutics Limited  (NASDAQ: KZIA)
 

Kazia Therapeutics Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2025, Kazia Therapeutics Limited's asset turnover ratio sequentially decreased to 0.01 in the fourth quarter (Jun 30 2025), this is lower than usual.

Within sector 189 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 3145 to 3619.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KZIA Asset Turnover Ratio (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Asset Change -57.95 % -72.36 % -78.26 % -71.92 % 12.84 %
Y / Y Revenue Change -98.31 % - - - 248000 %
Asset Turnover Ratio (TTM) 0.01 - - - 0.14
KZIA's Total Ranking # 3619 # 3145 # # #
Seq. Asset Change 52.14 % -12.86 % -24.57 % -57.95 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 190
Healthcare Sector # 526
Overall Market # 3619

Asset Turnover Ratio Statistics
High Average Low
0.47 0.12 0
(Jun 30 2018)   (Jun 30 2023)




KZIA Company Profile • Back to KZIA Efficiency Comparisons • Compare KZIA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Absci Corp  0.02 $ 4.138  Millions$ 222.795  Millions
Crispr Therapeutics Ag  0.02 $ 38.050  Millions$ 2,173.494  Millions
Co diagnostics Inc   0.02 $ 1.004  Millions$ 59.499  Millions
Prime Medicine Inc   0.02 $ 4.961  Millions$ 309.366  Millions
Aim Immunotech Inc   0.01 $ 0.121  Millions$ 8.143  Millions
Vivosim Labs Inc   0.01 $ 0.142  Millions$ 9.933  Millions
Vir Biotechnology Inc   0.01 $ 19.000  Millions$ 1,349.357  Millions
Dianthus Therapeutics Inc   0.01 $ 4.854  Millions$ 350.728  Millions
Ataibeckley Inc   0.01 $ 2.309  Millions$ 185.473  Millions
Lyra Therapeutics Inc   0.01 $ 0.770  Millions$ 63.498  Millions
Rallybio Corporation  0.01 $ 0.725  Millions$ 64.025  Millions
Clene Inc   0.01 $ 0.286  Millions$ 26.586  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 7.133  Millions
Precision Biosciences Inc  0.01 $ 1.261  Millions$ 130.746  Millions
Rafael Holdings Inc  0.01 $ 0.917  Millions$ 98.270  Millions
Vyne Therapeutics Inc   0.01 $ 0.476  Millions$ 61.061  Millions
Celldex Therapeutics inc   0.01 $ 5.791  Millions$ 761.849  Millions
Atrium Therapeutics Inc   0.01 $ 10.729  Millions$ 1,508.167  Millions
Kazia Therapeutics Limited  0.01 $ 0.042  Millions$ 6.061  Millions
Aclarion Inc   0.01 $ 0.063  Millions$ 9.136  Millions
Upstream Bio Inc   0.01 $ 2.723  Millions$ 397.777  Millions
Vistagen Therapeutics Inc   0.01 $ 0.646  Millions$ 94.854  Millions
Cardiff Oncology Inc   0.01 $ 0.545  Millions$ 80.158  Millions
Polomar Health Services, Inc. 0.00 $ 0.041  Millions$ 9.872  Millions
Roivant Sciences Ltd 0.00 $ 23.233  Millions$ 5,974.513  Millions
Lightwave Logic Inc 0.00 $ 0.094  Millions$ 35.780  Millions
Cartesian Therapeutics Inc 0.00 $ 1.026  Millions$ 422.090  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.020  Millions$ 9.444  Millions
Septerna Inc 0.00 $ 0.726  Millions$ 370.021  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.